1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Europe Vaccine Adjuvants Market – Key Market Dynamics

4.1       Europe Vaccine Adjuvants Market – Key Market Dynamics

4.2       Market Drivers

4.2.1         Rising Number of Infectious Disease Outbreaks and Pandemic

4.2.2         Approvals of Veterinary Vaccine Adjuvants

4.3       Market Restraints

4.3.1         Product Recalls and Adverse Effects

4.4       Market Opportunities

4.4.1         Advancements in Biotechnology and Immunology

4.5       Future Trends

4.5.1         Technological Advancements

4.6       Impact of Drivers and Restraints:

5.           Vaccine Adjuvants Market –Europe Market Analysis

5.1       Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

5.2       Europe Vaccine Adjuvants Market Forecast and Analysis

6.           Europe Vaccine Adjuvants Market Analysis – by Adjuvant Class

6.1       Overview

6.2       Mineral Salt Adjuvant

6.2.1         Overview

6.2.2         Mineral Salt Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.3       Emulsion Adjuvant

6.3.1         Overview

6.3.2         Emulsion Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.4       Liposome Adjuvant

6.4.1         Overview

6.4.2         Liposome Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.5       Others

6.5.1         Overview

6.5.2         Others: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.           Europe Vaccine Adjuvants Market Analysis – by Type

7.1       Human Vaccine Adjuvant

7.1.1         Overview

7.1.2         Human Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.2       Veterinary Vaccine Adjuvant

7.2.1         Overview

7.2.2         Veterinary Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.           Europe Vaccine Adjuvants Market –Country Analysis

8.1       Europe

8.1.1         Europe Vaccine Adjuvants Market

8.1.1.1            Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.1           Overview

8.1.1.1.2           Germany: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.3           Germany: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.1.4           Germany: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.2            United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.1           Overview

8.1.1.2.2           United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.3           United Kingdom: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.2.4           United Kingdom: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.3            France: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.1           Overview

8.1.1.3.2           France: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.3           France: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.3.4           France: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.4            Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.1           Overview

8.1.1.4.2           Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.3           Italy: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.4.4           Italy: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.5            Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.5.1           Overview

8.1.1.5.2           Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.5.3           Spain: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.5.4           Spain: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.6            Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.6.1           Overview

8.1.1.6.2           Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.6.3           Rest of Europe Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.6.4           Rest of Europe Vaccine Adjuvants Market Breakdown, by Type

9.           Industry Landscape

9.1       Overview

9.2       Growth Strategies in the Global Vaccine Adjuvants Market

9.3       Organic Developments

9.3.1         Overview

9.4       Inorganic Developments

9.4.1         Overview

10.        Company Profiles

10.1     SPI Pharma Inc

10.1.1       Key Facts

10.1.2       Business Description

10.1.3       Products and Services

10.1.4       Financial Overview

10.1.5       SWOT Analysis

10.1.6       Key Developments

10.2     GSK Plc

10.2.1       Key Facts

10.2.2       Business Description

10.2.3       Products and Services

10.2.4       Financial Overview

10.2.5       SWOT Analysis

10.2.6       Key Developments

10.3     CSL Ltd

10.3.1       Key Facts

10.3.2       Business Description

10.3.3       Products and Services

10.3.4       Financial Overview

10.3.5       SWOT Analysis

10.3.6       Key Developments

10.4     Seppic SA

10.4.1       Key Facts

10.4.2       Business Description

10.4.3       Products and Services

10.4.4       Financial Overview

10.4.5       SWOT Analysis

10.4.6       Key Developments

10.5     Dynavax Technologies Corp

10.5.1       Key Facts

10.5.2       Business Description

10.5.3       Products and Services

10.5.4       Financial Overview

10.5.5       SWOT Analysis

10.5.6       Key Developments

10.6     InvivoGen SAS

10.6.1       Key Facts

10.6.2       Business Description

10.6.3       Products and Services

10.6.4       Financial Overview

10.6.5       SWOT Analysis

10.6.6       Key Developments

10.7     Croda International Plc

10.7.1       Key Facts

10.7.2       Business Description

10.7.3       Products and Services

10.7.4       Financial Overview

10.7.5       SWOT Analysis

10.7.6       Key Developments

10.8     Novavax Inc

10.8.1       Key Facts

10.8.2       Business Description

10.8.3       Products and Services

10.8.4       Financial Overview

10.8.5       SWOT Analysis

10.8.6       Key Developments

10.9     Phibro Animal Health Corp

10.9.1       Key Facts

10.9.2       Business Description

10.9.3       Products and Services

10.9.4       Financial Overview

10.9.5       SWOT Analysis

10.9.6       Key Developments

11.        Appendix

11.1     About The Insight Partners

List of Tables

Table 1.             Europe Vaccine Adjuvants Market Segmentation

Table 2.             Europe Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)

Table 3.             Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 4.             Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 5.             United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 6.             United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 7.             France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 8.             France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 9.             Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 10.          Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 11.          Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 12.          Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 13.          Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 14.          Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 15.          Organic Developments Done by Companies

Table 16.          Inorganic Developments Done by Companies

List of Figures

Figure 1.           Europe Vaccine Adjuvants Market Segmentation, by Country

Figure 2.           Impact Analysis of Drivers and Restraints

Figure 3.           Europe Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030

Figure 4.           Europe Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)

Figure 5.           Mineral Salt Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 6.           Emulsion Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Liposome Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Others: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Europe Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)

Figure 10.        Human Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Veterinary Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Europe Vaccine Adjuvants Market – Revenue by Key Countries Revenue 2022 (US$ Million)

Figure 13.        Europe Vaccine Adjuvants Market (2022 and 2030)

Figure 14.        Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 15.        United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 16.        France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 17.        Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 18.        Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 19.        Rest of Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 20.        Growth Strategies in the Vaccine Adjuvants Market